Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acadia Pharmaceutica (NQ: ACAD )

21.47 USD +0.67 (+3.22%)
Official Closing Price Updated: 7:57 PM EDT, Apr 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,453,600
Open 20.82
Bid (Size) 21.20 (1)
Ask (Size) 21.50 (6)
Prev. Close 20.80
Today's Range 20.68 - 21.53
52wk Range 20.12 - 58.72
Shares Outstanding 160,047,470
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Acadia Pharmaceuticals Inc. (ACAD)
From GlobeNewswire News Releases
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact Its Attorneys Now, Securities Fraud Class Action Filed
From GlobeNewswire News Releases

Performance

YTD
-59.34%
-59.34%
1 Month
-20.48%
-20.48%
3 Month
-59.75%
-59.75%
6 Month
-47.69%
-47.69%
1 Year
-55.12%
-55.12%

More News

Read More
Pomerantz Law Firm Announces the Filing of a Class Action against Acadia Pharmaceuticals Inc. and Certain Officers - ACAD
From PR Newswire
Acadia Pharmaceuticals to Announce First Quarter 2021 Financial Results on May 5, 2021
From Business Wire News Releases
ACADIA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Acadia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
From Business Wire News Releases
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tags KIN ACAD Benzinga
From Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Acadia Pharmaceuticals Inc. (ACAD) on Behalf of Investors
From Business Wire News Releases
Stocks That Hit 52-Week Lows On Friday
Tags ELP Intraday Update Markets
From Benzinga
10 Biggest Price Target Changes For Wednesday
Tags AMAT DISCA Price Target Changes
From Benzinga
After FDA Rejects Acadia Dementia Drug, Analysts Lament Lack Of Near-term Stock Drivers
Tags Market News Analyst Color pharma
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.